John N. Abelson, Ph.D.
A molecular biologist and a founding stockholder of Annai Systems, Dr. Abelson received his doctorate from Johns Hopkins and did postdoctoral work with Francis Crick and Sydney Brenner in Cambridge. He was a professor of chemistry at the University of California, San Diego, from 1968 to 1982, as well as a professor of biology at California Institute of Technology from 1982 to 2004 where he was chairman of the division of biology from 1989 to 1995. Dr. Abelson is the author of more than 200 journal articles and is a member of the National Academy of Sciences. In 1984 he was a co-founder of Agouron Pharmaceuticals.
Harry Noller, Ph.D.
A founding shareholder and senior advisor to Annai Systems, Dr. Noller is the Robert L. Sinsheimer Professor of Molecular Biology at the University of California, Santa Cruz, and the director of the Center for Molecular Biology of RNA. His expertise is in protein synthesis, ribosome structure and function, and RNA. Dr. Noller is a member of the National Academy of Sciences and recipient of numerous awards, including the Paul Ehrlich Prize, the Gairdner International Award and the Rosenstiel Award in Basic Medical Research.
Melvin I. Simon, Ph.D.
Dr. Simon has made important contributions to many areas of bacterial and human molecular genetics, including the Human Genome Project. After receiving a doctorate from Brandeis University and completing a postdoctoral fellowship at Princeton University, he joined the faculty of University of California, San Diego, in 1965. He moved to the California Institute of Technology in 1982, where he became the chairman of the Division of Biology in 1995. He continues to serve as the Anne P. and Benjamin F. Biaggini Professor of Biological Sciences, Emeritus (active). In 2007, Dr. Simon re-joined the faculty at UCSD. He was elected to the National Academy of Sciences in 1985 and was a co-founder of Agouron Pharmaceuticals.